DiscoverX HitHunter® cAMP Assays
21 December 2016 | By DiscoverX Corporations
Optimized Assays for a Multitude of GPCR Applications...
List view / Grid view
21 December 2016 | By DiscoverX Corporations
Optimized Assays for a Multitude of GPCR Applications...
21 December 2016 | By DiscoverX Corporation
Designed for lead optimisation and safety profiling, DiscoverX’s SAFETYscan in vitro pharmacological profiling services improve off-target liability testing...
21 December 2016 | By DiscoverX Corporation
The movement of proteins between cellular compartments is essential for their specific biological role and the function of the cell...
21 December 2016 | By DiscoverX Corporation
Rapid Target Discovery, Validation, and Selectivity Determination...
21 October 2016 | By DiscoverX Corporation
Monitoring cellular drug penetration and drug-target interaction enables assessment of compound efficacy and confirmation of mode of action...
28 July 2016 | By DiscoverX Corporation
In vitro detection of potential in vivo toxicity and adverse events...
23 February 2016 | By DiscoverX Corporation
PathHunter cell-based pharmacotrafficking assays provide a simple and quantitative tool for broad pharmacological characterisation and interrogation of compound function in disease processes associated with protein trafficking and internalization due to protein misfolding...
23 February 2016 | By DiscoverX Corporation
The most comprehensive kinase inhibitor screening panel with over 480 kinase assays to screen against on a single technology platform...
22 February 2016 | By DiscoverX Corporation
The KILR Cytotoxicity Assay is a simple, non-radioactive and dye-free method to specifically measure target cancer cell cytotoxicity...
22 February 2016 | By DiscoverX Corporation
GPCRscan is a functional cell-based GPCR assay panel for profiling drug compounds during drug discovery...
19 February 2016 | By DiscoverX Corporation
Diversity PLUS Panel contains 12 human primary cell systems from multiple tissues that model human disease for predictive insight into drug efficacy and MOA...
19 February 2016 | By DiscoverX Corporation
PathHunter® Checkpoint Assays enable screening and potency assays for the development of immunotherapy drugs...
12 February 2016 | By DiscoverX Corporation
If you are looking to advance compounds to the clinic, BioMAP® phenotypic profiling services will predict the behaviour of your drug candidates in patients...
12 February 2016 | By DiscoverX Corporation
PathHunter® bioassays are cell-based assays that are highly validated, simple, and target specific to support biologics drug development...